Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[leifsmith]

I like the exploration you are reporting. There is something there of value. If I had the resources I would be doing something about it. The amount owed vs. the potential is insignificant - but it all would have to be put together well and well capitalized to make that clear.

Anatabine-citrate might eventually capture a large part of the Statin and NSAIDs markets. That's worth thinking about.